NCT02281214View on ClinicalTrials.gov

NGS Genome Analysis in Personalisation of Lung Cancer Treatment

NACompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

October 24, 2014

Primary Completion Date

November 17, 2014

Study Completion Date

November 17, 2018

Conditions
Lung Cancer
Interventions
OTHER

blood sample, biopsy

Blood samples and tumor biopsies will taken from patients before treatment and when tumor progression on therapy for Next Generation Sequencing (NGS) mutation analysis

Trial Locations (1)

21000

Centre Georges François Leclerc, Dijon

All Listed Sponsors
lead

Centre Georges Francois Leclerc

OTHER

NCT02281214 - NGS Genome Analysis in Personalisation of Lung Cancer Treatment | Biotech Hunter | Biotech Hunter